Kellokumpu-Lehtinen P - Search Results

1

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma.

Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Luukkaala T, Tammela TL, Martikainen PM. Kallio JP, et al. Br J Cancer. 2003 Oct 6;89(7):1266-9. doi: 10.1038/sj.bjc.6601241. Br J Cancer. 2003. PMID: 14520458 Free PMC article.

2

Renal cell carcinoma MIB-1, Bax and Bcl-2 expression and prognosis.

Kallio JP, Hirvikoski P, Helin H, Luukkaala T, Tammela TL, Kellokumpu-Lehtinen P, Martikainen PM. Kallio JP, et al. J Urol. 2004 Dec;172(6 Pt 1):2158-61. doi: 10.1097/01.ju.0000144334.97639.bf. J Urol. 2004. PMID: 15538222

3

Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.

Kallio JP, Mahlamäki EH, Helin H, Karhu R, Kellokumpu-Lehtinen P, Tammela TL. Kallio JP, et al. Scand J Urol Nephrol. 2004;38(3):225-30. doi: 10.1080/00365590310025399. Scand J Urol Nephrol. 2004. PMID: 15204376

4

Antioxidant enzymes in renal cell carcinoma.

Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula LV. Soini Y, et al. Histol Histopathol. 2006 Feb;21(2):157-65. doi: 10.14670/HH-21.157. Histol Histopathol. 2006. PMID: 16329040

5

Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.

Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Kang SW, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula VL. Soini Y, et al. APMIS. 2006 May;114(5):329-37. doi: 10.1111/j.1600-0463.2006.apm_315.x. APMIS. 2006. PMID: 16725008

6

Genetic variation in platelet integrin alphabeta (GPIIb/IIIa) and the metastatic potential of renal cell carcinoma.

Kallio JP, Mikkelsson J, Tammela TL, Karhunen PJ, Kellokumpu-Lehtinen P. Kallio JP, et al. BJU Int. 2006 Jul;98(1):201-4. doi: 10.1111/j.1464-410X.2006.06196.x. BJU Int. 2006. PMID: 16831169

7

p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.

Hirvikoski P, Kumpulainen E, Virtaniemi J, Johansson R, Haapasalo H, Marin S, Halonen P, Helin H, Raitiola H, Pukander J, Kellokumpu-Lehtinen P, Kosma VM. Hirvikoski P, et al. J Clin Oncol. 1997 Sep;15(9):3111-20. doi: 10.1200/JCO.1997.15.9.3111. J Clin Oncol. 1997. PMID: 9294474

8

A randomised dose-finding phase II study on ifosfamide in metastatic hormone-refractory prostate cancer (HRPC).

Hervonen P, Lehtinen T, Tammela TL, Kellokumpu-Lehtinen P. Hervonen P, et al. J Exp Clin Cancer Res. 2002 Jun;21(2):177-80. J Exp Clin Cancer Res. 2002. PMID: 12148574 Clinical Trial.

9

A combination of subcutaneous recombinant interleukin-2 and recombinant interferon-alpha in the treatment of advanced renal cell carcinoma or melanoma.

Vuoristo M, Jantunen I, Pyrhönen S, Muhonen T, Kellokumpu-Lehtinen P. Vuoristo M, et al. Eur J Cancer. 1994;30A(4):530-2. doi: 10.1016/0959-8049(94)90433-2. Eur J Cancer. 1994. PMID: 8018415 Clinical Trial.

10

Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial.

Ahlgren GM, Flodgren P, Tammela TLJ, Kellokumpu-Lehtinen P, Borre M, Angelsen A, Iversen JR, Sverrisdottir A, Jonsson E, Sengelov L; Investigators of the Scandinavian Prostate Cancer Study Number 12. Ahlgren GM, et al. Eur Urol. 2018 Jun;73(6):870-876. doi: 10.1016/j.eururo.2018.01.012. Epub 2018 Feb 1. Eur Urol. 2018. PMID: 29395502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

315 results

Search Page

Filters